Short Bowel Syndrome (SBS) is a devastating clinical disorder that has a high prevalence of mortality and morbidity and takes a severe socioeconomic toll on patients. The hallmark of SBS is poor absorption of fluid and vital nutrients due to insufficient function or lack of large portions of the small intestine. Surgical and pharmacological means to enhance or grow the remaining intestinal tissue have thus far not been successful. In the U.S., the annual prevalence of patients requiring TPN due to SBS is approximately 12,000 per year. The annual cost of TPN is over $100,000 per year per patient. One potential long term treatment for SBS would be the development of a living, tissue engineered small intestinal graft to replace the lost tissue. The goal of this renewal grant is to use our existing biodegradable and biocompatible elastomers that can be tailored for specific soft tissue applications, to develop new approaches for treating intestinal defects. Previous scaffolds have not provided sufficient structural guidance to promote the regeneration of a fully biomimetic small intestinal tissue. A major limitation of previous approaches has been the lack of proper smooth muscle formation and intestinal motility and there has been a lack of morphological guidance to generate biomimetic tissue structures. In particular, given the unique multi-laminar and hierarchically-structured nature of small intestine, one promising new approach would be to microfabricate scaffolds from soft bioresorbable elastomers. We believe that these materials can be harnessed via microfabrication to create an in vitro model of small intestinal tissue that may also serve as a functional tissue engineered intestine, and a useful in vitro model for testing new drugs and other agents. Our overall hypothesis is that functional tissue engineering of small intestine requires microfabricated elastomeric scaffolds capable of guiding the formation of the mucosa and muscle layers and respective nutrient transport and peristalsis functions.
We aim to: 1. Develop microfabricated elastomeric scaffolds for functional maturation of the mucosa layer of tissue engineered small intestine. 2. Investigate the use of microfabricated elastomeric scaffolds for functional maturation of the muscular is propria layer of tissue engineered small intestine. 3. Develop patches and tubes of microfabricated elastomeric scaffolds for functional maturation of mucosa and muscular is propria layers of tissue engineered small intestine and test in vivo.

Public Health Relevance

The goal of this renewal grant is to use our existing biodegradable and biocompatible elastomers that can be tailored for specific soft tissue applications, to develop new approaches for treating intestinal defects. We will address the overall hypothesis that functional tissue engineering of biomimetic small intestine requires microfabricated elastomeric scaffolds capable of guiding the formation of the mucosa and muscular is propria layers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE013023-13
Application #
8209250
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Lumelsky, Nadya L
Project Start
1998-09-15
Project End
2015-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
13
Fiscal Year
2012
Total Cost
$398,481
Indirect Cost
$121,513
Name
Massachusetts Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
McLean, Will J; Yin, Xiaolei; Lu, Lin et al. (2017) Clonal Expansion of Lgr5-Positive Cells from Mammalian Cochlea and High-Purity Generation of Sensory Hair Cells. Cell Rep 18:1917-1929
Doloff, Joshua C; Veiseh, Omid; Vegas, Arturo J et al. (2017) Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates. Nat Mater 16:671-680
Vegas, Arturo J; Veiseh, Omid; Doloff, Joshua C et al. (2016) Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 34:345-52
Vegas, Arturo J; Veiseh, Omid; G├╝rtler, Mads et al. (2016) Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med 22:306-11
Langer, Robert; Vacanti, Joseph (2016) Advances in tissue engineering. J Pediatr Surg 51:8-12
Yin, Xiaolei; Mead, Benjamin E; Safaee, Helia et al. (2016) Engineering Stem Cell Organoids. Cell Stem Cell 18:25-38
Jhunjhunwala, Siddharth; Alvarez, David; Aresta-DaSilva, Stephanie et al. (2016) Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation. J Leukoc Biol 100:253-60
Lim, Dong-Kwon; Wylie, Ryan G; Langer, Robert et al. (2016) Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF(165). Biomaterials 77:130-138
Veiseh, Omid; Doloff, Joshua C; Ma, Minglin et al. (2015) Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater 14:643-51
Zhang, Sufeng; Ermann, Joerg; Succi, Marc D et al. (2015) An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med 7:300ra128

Showing the most recent 10 out of 74 publications